Patents by Inventor Sarah Mousa ASIRI

Sarah Mousa ASIRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for terminating cancer cells with an azole-based compound
    Patent number: 11738091
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therepeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Grant
    Filed: November 17, 2022
    Date of Patent: August 29, 2023
    Assignee: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa Asiri, Firdos Alam Khan, Ayhan Bozkurt
  • METHOD FOR TERMINATING CANCER CELLS WITH AN AZOLE-BASED COMPOUND
    Publication number: 20230087061
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therepeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Application
    Filed: November 17, 2022
    Publication date: March 23, 2023
    Applicant: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa ASIRI, Firdos Alam KHAN, Ayhan BOZKURT
  • Method for making a conjugate azole-based surface modified silicon dioxide nanoparticle
    Patent number: 11564994
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therapeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: January 31, 2023
    Assignee: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa Asiri, Firdos Alam Khan, Ayhan Bozkurt
  • METHOD FOR MAKING A CONJUGATE AZOLE-BASED SURFACE MODIFIED SILICON DIOXIDE NANOPARTICLE
    Publication number: 20210268124
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therapeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Application
    Filed: May 5, 2021
    Publication date: September 2, 2021
    Applicant: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa ASIRI, Firdos Alam KHAN, Ayhan BOZKURT
  • Material production and application using azole functionalized nanosilica
    Patent number: 11103595
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therapeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: August 31, 2021
    Assignee: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa Asiri, Firdos Alam Khan, Ayhan Bozkurt
  • MATERIAL PRODUCTION AND APPLICATION USING AZOLE FUNCTIONALIZED NANOSILICA
    Publication number: 20200323996
    Abstract: A combination therapy involving different therapeutic molecules can enhance and improve the therapeutic potentials. An effective therapeutic strategy conjugates silica (SiO2) nanoparticles with, e.g., 3-glycidyloxypropyl, trimethoxysilane and azoles, e.g., 1,2,4-triazole (Tri), 3-aminotriazole (ATri), 5-aminetetrazole (Atet), imidazole (Imi). These exemplary materials—classified as SiO2-3GPS-Tri (Conj. 1), SiO2-3GPS-Atri (Conj. 2), SiO2-3GPS-Atet (Conj. 3), SiO2-3GPS-Btri (Conj. 4), and SiO2-3GPS-Imi (Conj. 5)—can amplify targeting of therepeutics for human colorectal carcinoma cells (HCT-116), enhancing anti-cancer effects.
    Type: Application
    Filed: April 10, 2019
    Publication date: October 15, 2020
    Applicant: Imam Abdulrahman Bin Faisal University
    Inventors: Sarah Mousa ASIRI, Firdos Alam KHAN, Ayhan BOZKURT